Stay updated on Pembrolizumab SBRT in TKI mRCC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab SBRT in TKI mRCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab SBRT in TKI mRCC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    A new revision tag, Revision: v3.5.4, was added and the previous Revision: v3.5.3 was removed. This is a metadata update to the page's revision history and does not modify the study information.
    Difference
    0.1%
    Check dated 2026-05-15T05:12:47.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The page’s footer version label was updated from **Revision: v3.5.2** to **Revision: v3.5.3**, reflecting a non-content site update.
    Difference
    0.1%
    Check dated 2026-04-23T21:56:32.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and removed Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-16T12:36:10.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added and Revision: v3.4.3 was removed.
    Difference
    0.1%
    Check dated 2026-03-18T21:00:09.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3. No changes visible in the study details content.
    Difference
    0.1%
    Check dated 2026-03-11T17:39:49.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Only visual styling changes were observed (header/footer and layout). The core study content, including eligibility criteria and outcomes, remains unchanged.
    Difference
    0.1%
    Check dated 2026-02-25T09:20:05.000Z thumbnail image

Stay in the know with updates to Pembrolizumab SBRT in TKI mRCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab SBRT in TKI mRCC Clinical Trial page.